tryptophan has been researched along with Liver Cirrhosis, Biliary in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dehpour, AR; Faghir-Ghanesefat, H; Guillemin, GJ; Mani, AR; Rashidian, A; Shayesteh, S; Tavangar, SM | 1 |
| Imai, Y | 1 |
2 other study(ies) available for tryptophan and Liver Cirrhosis, Biliary
| Article | Year |
|---|---|
1-Methyl tryptophan, an indoleamine 2,3-dioxygenase inhibitor, attenuates cardiac and hepatic dysfunction in rats with biliary cirrhosis.
Topics: Animals; Liver Cirrhosis, Biliary; Rats; Tryptophan | 2021 |
[Hepatobiliary functions in primary biliary cirrhosis--assessment with 99mTc-PMT hepatobiliary scintigraphy].
Topics: Adult; Aged; Biliary Tract; Female; Humans; Liver; Liver Cirrhosis, Biliary; Male; Middle Aged; Organotechnetium Compounds; Pyridoxal; Radionuclide Imaging; Tryptophan | 1994 |